| DAA1181 |
Morning IGF1 decline |
Physiological |
plasma |
Human |
IGF1 |
51.0% Decrease Hormone Level |
|
| DAA2058 |
Mosaic abnormalities increase |
Physiological |
blood, oral cavity |
Human |
— |
— |
|
| DAA2434 |
nerve growth factor; beta polypeptide precursor decreases with age |
Molecular |
mesenchymal stem cell |
Human |
NGF |
22.5% Decrease DNA Methylation |
|
| DAA933 |
No changes in erythroid and myeloid progenitor cells evident |
Physiological |
myeloid progenitor cell |
Human |
— |
— |
|
| DAA609 |
Non-Hodgkin's lymphoma |
Pathological |
hematological system |
Human |
— |
SeriesMorbidity |
|
| DAA2013 |
Number and differentiation potential of adipose tissue-derived stem cells declines with age |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA934 |
Number of mature B cells leaving the bone marrow declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
| DAA701 |
Oxidative increase in cystine/cysteine ratio |
Physiological |
plasma |
Human |
— |
— |
|
| DAA2456 |
PDZ and LIM domain 2 isoform 3 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PDLIM2 |
43.9% Increase DNA Methylation |
|
| DAA917 |
Plasma and urinary catecholamine elevation after stimuli |
Physiological |
plasma |
Human |
— |
— |
|
| DAA935 |
Pro-B cell generation and differentiation declines |
Physiological |
bone marrow, B cell |
Human |
— |
— |
|
| DAA2022 |
Prolactin decreases in females |
Physiological |
plasma |
Human |
— |
— |
|
| DAA920 |
Prolactin increases in males |
Physiological |
plasma |
Human |
— |
— |
|
| DAA676 |
Proliferation rate of mesenchymal stem cells is reduced |
Physiological |
mesenchymal stem cell |
Human |
— |
— |
|
| DAA677 |
Proportion of apoptotic cells may be increased |
Physiological |
mesenchymal stem cell |
Human |
TP53 |
— |
|
| DAA2446 |
protein kinase C binding protein 1 isoform a increases with age |
Molecular |
mesenchymal stem cell |
Human |
ZMYND8 |
19.9% Increase DNA Methylation |
|
| DAA2447 |
protein kinase N1 isoform 2 increases with age |
Molecular |
mesenchymal stem cell |
Human |
PKN1 |
27.7% Increase DNA Methylation |
|
| DAA702 |
Ratio of oxidized to unoxidized plasma albumin increases |
Physiological |
plasma |
Human |
— |
— |
|
| DAA2015 |
Regulation of the acid-base equilibrium of the blood unchanged |
Physiological |
blood |
Human |
— |
— |
|
| DAA932 |
Renewal capacity declines |
Physiological |
hematopoietic stem cells |
Human |
— |
— |
|
| DAA2436 |
selenium binding protein 1 decreases with age |
Molecular |
mesenchymal stem cell |
Human |
SELENBP1 |
20.8% Decrease DNA Methylation |
|
| DAA2448 |
semaphorin 3B isoform 2 precursor increases with age |
Molecular |
mesenchymal stem cell |
Human |
SEMA3B |
19.1% Increase DNA Methylation |
|
| DAA587 |
Septicemia |
Pathological |
blood |
Human |
— |
SeriesMorbidity |
|
| DAA2451 |
serine (or cysteine) proteinase inhibitor; clade A (alpha-1 antiproteinase; antitrypsin); member 12 increases with age |
Molecular |
mesenchymal stem cell |
Human |
SERPINA12 |
52.7% Increase DNA Methylation |
|
| DAA1199 |
Serum klotho |
Physiological |
plasma |
Human |
KL |
Increase Hormone Level |
|